Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0002040705-26-000002

Options or other derivatives

  • Chief Financial Officer acquired 26,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DeLucia David · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +26,000 26,000 D
Loading xslF345X05/form4-02062026_020236.xml…